Prisca Yameogo

Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial

Mehreen S. Datoo, Hamtandi Magloire Natama, Ousmane Traoré et al. · The Lancet · 2021 · 458 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial

Mehreen S. Datoo, Hamtandi Magloire Natama, Duncan Bellamy et al. · The Lancet Infectious Diseases · 2022 · 288 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

High Efficacy of a Low Dose Candidate Malaria Vaccine, R21 in 1 Adjuvant Matrix-M™, with Seasonal Administration to Children in Burkina Faso

Mehreen S. Datoo, Hamtandi Magloire Natama, Ousmane Traoré et al. · SSRN Electronic Journal · 2021 · 15 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17